These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 35643375

  • 1. Oral Coenzyme Q10 supplementation leads to better preservation of kidney function in steroid-resistant nephrotic syndrome due to primary Coenzyme Q10 deficiency.
    Drovandi S, Lipska-Ziętkiewicz BS, Ozaltin F, Emma F, Gulhan B, Boyer O, Trautmann A, Xu H, Shen Q, Rao J, Riedhammer KM, Heemann U, Hoefele J, Stenton SL, Tsygin AN, Ng KH, Fomina S, Benetti E, Aurelle M, Prikhodina L, Schreuder MF, Tabatabaeifar M, Jankowski M, Baiko S, Mao J, Feng C, Liu C, Sun S, Deng F, Wang X, Clavé S, Stańczyk M, Bałasz-Chmielewska I, Fila M, Durkan AM, Levart TK, Dursun I, Esfandiar N, Haas D, Bjerre A, Anarat A, Benz MR, Talebi S, Hooman N, Ariceta G, PodoNet Consortium, mitoNET Consortium, CCGKDD Consortium, Schaefer F.
    Kidney Int; 2022 Sep; 102(3):604-612. PubMed ID: 35643375
    [Abstract] [Full Text] [Related]

  • 2. CoQ10 supplementation rescues nephrotic syndrome through normalization of H2S oxidation pathway.
    Kleiner G, Barca E, Ziosi M, Emmanuele V, Xu Y, Hidalgo-Gutierrez A, Qiao C, Tadesse S, Area-Gomez E, Lopez LC, Quinzii CM.
    Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3708-3722. PubMed ID: 30251690
    [Abstract] [Full Text] [Related]

  • 3. Response to Early Coenzyme Q10 Supplementation Is not Sustained in CoQ10 Deficiency Caused by CoQ2 Mutation.
    Eroglu FK, Ozaltin F, Gönç N, Nalçacıoğlu H, Özçakar ZB, Yalnızoğlu D, Güçer Ş, Orhan D, Eminoğlu FT, Göçmen R, Alikaşifoğlu A, Topaloğlu R, Düzova A.
    Pediatr Neurol; 2018 Nov; 88():71-74. PubMed ID: 30337132
    [Abstract] [Full Text] [Related]

  • 4. COQ2 nephropathy: a treatable cause of nephrotic syndrome in children.
    Starr MC, Chang IJ, Finn LS, Sun A, Larson AA, Goebel J, Hanevold C, Thies J, Van Hove JLK, Hingorani SR, Lam C.
    Pediatr Nephrol; 2018 Jul; 33(7):1257-1261. PubMed ID: 29637272
    [Abstract] [Full Text] [Related]

  • 5. Primary coenzyme Q10 Deficiency-6 (COQ10D6): Two siblings with variable expressivity of the renal phenotype.
    Yuruk Yildirim Z, Toksoy G, Uyguner O, Nayir A, Yavuz S, Altunoglu U, Turkkan ON, Sevinc B, Gokcay G, Kurkcu Gunes D, Kiyak A, Yilmaz A.
    Eur J Med Genet; 2020 Jan; 63(1):103621. PubMed ID: 30682496
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. COQ8B nephropathy: Early detection and optimal treatment.
    Song X, Fang X, Tang X, Cao Q, Zhai Y, Chen J, Liu J, Zhang Z, Xiang T, Qian Y, Wu B, Wang H, Zhou W, Liu C, Shen Q, Xu H, Rao J.
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1360. PubMed ID: 32543055
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-term follow-up results of patients with ADCK4 mutations who have been diagnosed in the asymptomatic period: effects of early initiation of CoQ10 supplementation.
    Atmaca M, Gülhan B, Atayar E, Bayazıt AK, Candan C, Arıcı M, Topaloğlu R, Özaltın F.
    Turk J Pediatr; 2019 Aug; 61(5):657-663. PubMed ID: 32104996
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bypassing human CoQ10 deficiency.
    Herebian D, López LC, Distelmaier F.
    Mol Genet Metab; 2018 Mar; 123(3):289-291. PubMed ID: 29246431
    [Abstract] [Full Text] [Related]

  • 16. Primary coenzyme Q10 nephropathy, a potentially treatable form of steroid-resistant nephrotic syndrome.
    Tan W, Airik R.
    Pediatr Nephrol; 2021 Nov; 36(11):3515-3527. PubMed ID: 33479824
    [Abstract] [Full Text] [Related]

  • 17. Ubiquinol-10 ameliorates mitochondrial encephalopathy associated with CoQ deficiency.
    García-Corzo L, Luna-Sánchez M, Doerrier C, Ortiz F, Escames G, Acuña-Castroviejo D, López LC.
    Biochim Biophys Acta; 2014 Jul; 1842(7):893-901. PubMed ID: 24576561
    [Abstract] [Full Text] [Related]

  • 18. Effects of CoQ10 Replacement Therapy on the Audiological Characteristics of Pediatric Patients with COQ6 Variants.
    Nam DW, Park SS, Lee SM, Suh MW, Park MK, Song JJ, Choi BY, Lee JH, Oh SH, Moon KC, Ahn YH, Kang HG, Cheong HI, Kim JH, Lee SY.
    Biomed Res Int; 2022 Jul; 2022():5250254. PubMed ID: 36124066
    [Abstract] [Full Text] [Related]

  • 19. Coenzyme Q10 as a therapy for mitochondrial disease.
    Hargreaves IP.
    Int J Biochem Cell Biol; 2014 Apr; 49():105-11. PubMed ID: 24495877
    [Abstract] [Full Text] [Related]

  • 20. [Coenzyme Q(10) treatment for one child with COQ6 gene mutation induced nephrotic syndrome and literature review].
    Cao Q, Li GM, Xu H, Shen Q, Sun L, Fang XY, Liu HM, Guo W, Zhai YH, Wu BB.
    Zhonghua Er Ke Za Zhi; 2017 Feb 02; 55(2):135-138. PubMed ID: 28173653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.